Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON)

the NAPKON Study Group, Oct 2024, In: Infection. 52, 5, p. 1813-1829 17 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG

DKTK-ROG, 1 Jun 2016, In: Clinical Cancer Research. 22, 11, p. 2639-2649 11 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study

Lococo, F., Boldrini, L., Diepriye, C-D., Evangelista, J., Nero, C., Flamini, S., Minucci, A., & 26 othersDe Paolis, E., Vita, E., Cesario, A., Annunziata, S., Calcagni, M. L., Chiappetta, M., Cancellieri, A., Larici, A. R., Cicchetti, G., Troost, E. G. C., Ádány, R., Farré, N., Öztürk, E., Van Doorne, D., Leoncini, F., Urbani, A., Trisolini, R., Bria, E., Giordano, A., Rindi, G., Sala, E., Tortora, G., Valentini, V., Boccia, S., Margaritora, S. & Scambia, G., 13 Jun 2023, In: BMC cancer. 23, 1, 540.

Research output: Contribution to journal › Research article › Contributed › peer-review

DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy

Tawk, B., Rein, K., Schwager, C., Knoll, M., Wirkner, U., Hörner-Rieber, J., Liermann, J., & 19 othersKurth, I., Balermpas, P., Rödel, C., Linge, A., Löck, S., Lohaus, F., Tinhofer, I., Krause, M., Stuschke, M., Grosu, A. L., Zips, D., Combs, S. E., Belka, C., Stenzinger, A., Herold-Mende, C., Baumann, M., Schirmacher, P., Debus, J. & Abdollahi, A., 15 Aug 2023, In: Clinical cancer research. 29 (2023), 16, p. 3051-3064 14 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Minderjährige in klinischen Prüfungen: Ethische Abwägungen ihres Einbezugs am Beispiel der indizierten Prävention psychotischer Erkrankungen

CARE-Konsortium, 1 Sept 2024, In: Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie. 52, 5, p. 261-289 29 p.

Research output: Contribution to journal › Review article › Contributed › peer-review

Short term starvation potentiates the efficacy of chemotherapy in triple negative breast cancer via metabolic reprogramming

Pateras, I. S., Williams, C., Gianniou, D. D., Margetis, A. T., Avgeris, M., Rousakis, P., Legaki, A. I., & 16 othersMirtschink, P., Zhang, W., Panoutsopoulou, K., Delis, A. D., Pagakis, S. N., Tang, W., Ambs, S., Warpman Berglund, U., Helleday, T., Varvarigou, A., Chatzigeorgiou, A., Nordström, A., Tsitsilonis, O. E., Trougakos, I. P., Gilthorpe, J. D. & Frisan, T., Dec 2023, In: Journal of translational medicine. 21, 1, 169.

Research output: Contribution to journal › Research article › Contributed › peer-review

Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial

AGO Study Group, GINECO Study Group & Canzler, U., 1 Feb 2023, In: Journal of Clinical Oncology. 41, 4, p. 893-902 13 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer

PAOLA-1 investigators, 1 Nov 2023, In: Clinical Cancer Research. 29, 21, p. 4419-4429 11 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers

Niger, M., Nichetti, F., Casadei-Gardini, A., Morano, F., Pircher, C., Tamborini, E., Perrone, F., & 26 othersCanale, M., Lipka, D. B., Vingiani, A., Agnelli, L., Dobberkau, A., Hüllein, J., Korell, F., Heilig, C. E., Pusceddu, S., Corti, F., Droz, M., Ulivi, P., Prisciandaro, M., Antista, M., Bini, M., Cattaneo, L., Milione, M., Glimm, H., Köhler, B. C., Pruneri, G., Hübschmann, D., Fröhling, S., Mazzaferro, V., Pietrantonio, F., Di Bartolomeo, M. & de Braud, F., Jul 2022, In: Molecular oncology. 16, 14, p. 2733-2746 14 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial

Heilig, C. E., Horak, P., Kreutzfeldt, S., Teleanu, V., Mock, A., Renner, M., Bhatti, I. A., & 25 othersHutter, B., Hüllein, J., Fröhlich, M., Uhrig, S., Süße, H., Heiligenthal, L., Ochsenreither, S., Illert, A. L., Vogel, A., Desuki, A., Heinemann, V., Heidegger, S., Bitzer, M., Scheytt, M., Brors, B., Hübschmann, D., Baretton, G., Stenzinger, A., Steindorf, K., Benner, A., Jäger, D., Heining, C., Glimm, H., Fröhling, S. & Schlenk, R. F., Dec 2021, In: ESMO open. 6, 6, 100310.

Research output: Contribution to journal › Research article › Contributed › peer-review